Alert detail
FDA Approval: ARGATROBAN IN SODIUM CHLORIDE (ARGATROBAN) — Type 5 - New Formulation or New Manufacturer
Policy ID: FDA-NDA022434Specialty: CardiologyAdded: 6/13/2026Effective: 2011-06-29billing update
Full alert analysis requires a subscription
Subscribe to access the complete alert summary, AI-generated action recommendations, source document links, LCD revision comparisons, and related alerts.